Diet, exercise & lifestyle × glycemic control

TrialCardiovascular diabetology2014

Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study.

Manfredi Rizzo et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 64 people · 2014

No range given

Reported higher lipids, no range given

+18.0percentage points

As reported

difference 18 %, no interval

No range given

Reported lower glycemic control, no range given

−1.90percentage points

As reported

difference −1.90 %, no interval

Two numbers in the abstract

the abstract, start to end

whereas HDL-cholesterol increased by 18% (p < 0.01 for all lipid

decreased by 2.1 mmol/l and HbA1c by 1.9% (p < 0.01 for all).

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Lipids
18
Glycemic control
−1.90
GLP-1 receptor agonistsDiet, exercise & lifestyleGlycemic controlLipids
1 / 3

57 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 24559258